Comparison of the qSOFA and CRB-65 for risk prediction in patients with community-acquired pneumonia
- 1.2k Downloads
KeywordsOrgan Dysfunction Sofa Score Mortality Prediction Multicenter Validation Acute Organ Dysfunction
Grants: CAPNETZ was founded by a BMBF Grant (01KI07145) 2001-2011. CAPNETZ is a multidisciplinary approach to better understand and treat patients with community-acquired pneumonia. The network has only been made possible by the contribution of many investigators. We are especially indebted to the work of the investigators in the local clinical centers (LCC) who established and kept contact to all practitioners, physicians, and respiratory specialists cooperating within the network. Members of the CAPNETZ study group except the authors: M. Dreher, C. Cornelissen (Aachen); W. Knüppel (Bad Arolsen); D. Stolz (Basel); N. Suttorp, P. Creutz (Berlin, Charité); T. Bauer, T. Sabha (Berlin); W. Pankow, A. Lies, D. Thiemig (Berlin-Neukölln); B. Hauptmeier, S. Ewig, D. Wehde (Bochum); M. Prediger, S. Schmager (Cottbus); G. Höffken, M. Kolditz, B. Schulte-Hubbert, S. Langner (Dresden), T. Welte, G. Barten, M. Abrahamczik, J. Naim, W. Kröner, T. Illig, N. Klopp (Hannover); P. Ravn, A. Vestergaard-Jensen, G. Baunbaek-Knudsen (Hillerød); C. Kroegel, M. Pletz, J. Happe, J. Frosinski, J. Winning, A. Moeser (Jena); K. Dalhoff, K. Dageförde, K. Franzen, F. Hyzy, H. Schmieg, P. Parschke, P. Thiemann, J. Ahrens, T. Hardel (Lübeck); G. Rohde, J. Drijkoningen (Maastricht); H. Buschmann, R. Kröning (Paderborn); H. Schütte (Potsdam), T. Schaberg, I. Hering (Rotenburg/Wümme); C. Kropf-Sanchen (Ulm); T. Illmann, M. Wallner (Ulm); and all study nurses.
Compliance with ethical standards
Conflicts of interest
Dr. Kolditz reports personal fees from Pfizer, Gilead, Novartis, Astra-Zeneca, Basilea, Böhringer-Ingelheim, Bayer, outside the submitted work. Dr. Scherag reports grants from Federal Ministry of Education and Research (BMBF), Germany, during the conduct of the study. Dr. Rohde reports personal fees from Pfizer, Novartis, Bayer, Astra Zeneca and Chiesi outside the submitted work. Dr. Welte reports grants from Ministry of Research and Education, during the conduct of the study; personal fees from AstraZeneca, Bayer, Basilea, Infectopharm, Pfizer, outside the submitted work. Dr. Ewig and Dr. Pletz have nothing to disclose.